Detection of Ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis Serogroup Y Isolates, United States, 2019–2020

COLA is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. Below is a link to the most recent message about the detection of ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis isolates in the United States in 2019 to 2020.

Detection of Ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis Serogroup Y Isolates, United States, 2019–2020

Meningococcal disease, which typically presents as meningitis or meningococcemia, is a life-threatening illness that requires prompt antibiotic treatment for patients, and antibiotic prophylaxis for their close contacts. Neisseria meningitidis isolates in the United States have been largely susceptible to the antibiotics recommended for treatment and prophylaxis.

Read more here.